Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Methylation of CpG dinucleotides and/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients

Oncogene volume 22, pages 1070–1072 (2003)Cite this article

Abstract

It has been shown that methylation of CpG dinucleotides located in the promoter region of TP53 is associated with low expression levels of this gene. We have analysed the methylation status of one CpG dinucleotide and of three CCWGG motifs, also located in the promoter region of the gene, in bone marrow samples obtained from patients with acute lymphoblastic leukemia (ALL). Eight out of 25 samples analysed showed methylation of either the CpG dinucleotide, the CCWGG motifs or both. Relative to nonmethylated leukemia samples, TP53 expression levels were decreased in all methylated samples in which TP53 expression could be measured. Methylation of CpG and CCWGG motifs in the promoter of TP53 could represent a novel mechanism leading to functional impairment of this tumor suppressor gene in ALL.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Agirre X, García-Delgado M, Calasanz MJ, Larrayoz MJ, Novo FJ and Vizmanos JL . (2002). BioTechniques, 32, 1064–1070.

  • Bienz-Tadmor B, Zakut-Houri R, Libresco S, Givol D and Oren M . (1985). EMBO J., 4, 3209–3213.

  • Davis CD, Uthus EO and Finley JW . (2000). J. Nutr., 130, 2903–2909.

  • Fenaux P and Preudhomme C . (1997). Br. J. Haematol., 98, 502–511.

  • Herman JG, Jen J, Merlo A and Baylin SB . (1996). Cancer Res., 56, 722–727.

  • Kang JH, Kim SJ, Noh DY, Park IA, Choe KJ, Yoo OJ and Kang HS . (2001). Lab. Invest., 81, 573–579.

  • Malone CS, Miner MD, Doerr JR, Jackson JP, Jacobsen SE, Wall R and Teitell M . (2001). Proc. Natl. Acad. Sci. USA, 98, 10404–10409.

  • Mass MJ and Wang L . (1997). Mutat. Res., 386, 263–277.

  • Pogribny IP and James SJ . (2002). Cancer Lett., 176, 169–174.

  • Pogribny IP, Pogribna M, Christman JK and James SJ . (2000). Cancer Res., 60, 588–594.

  • Roman-Gomez J, Castillejo JA, Jimenez A, Gonzalez MG, Moreno F, Rodriguez MC, Barrios M, Maldonado J and Torres A . (2002). Blood, 99, 2291–2296.

  • Schroeder M and Mass MJ . (1997). Biochem. Biophys. Res. Commun., 235, 403–406.

  • Schutte M, Hruban RH, Geradts J, Maynard R, Hilgers W, Rabindran SK, Moskaluk CA, Hahn SA, Schwarte-Waldhoff I, Schmiegel W, Baylin SB, Kern SE and Herman JG . (1997). Cancer Res., 57, 3126–3130.

  • Tuck SP and Crawford L . (1989). Mol. Cell. Biol., 9, 2163–2172.

  • Venkatachalam S, Shi YP, Jones SN, Vogel H, Bradley A, Pinkel D and Donehower LA . (1998). EMBO J., 17, 4657–4667.

Download references

Acknowledgements

We are grateful to José P Román for his assistance with densitometric analyses. This work is supported in part by Grant 48/99 from the Department of Health of the Government of Navarra, Spain; and Grant 01/132 from the Fondo de Investigaciones Sanitarias; XA is supported by a grant from the Department of Education, Universities and Research of the Government of the Basque Country, Spain (BFI99.1.0AE).

Author information

Authors and Affiliations

  1. Department of Genetics, School of Sciences, University of Navarra, Pamplona, E-31080, Navarra, Spain

    Xabier Agirre, José Luis Vizmanos, María J Calasanz, Marina García-Delgado, María J Larráyoz & Francisco J Novo

Authors
  1. Xabier Agirre
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. José Luis Vizmanos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. María J Calasanz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marina García-Delgado
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. María J Larráyoz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Francisco J Novo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to José Luis Vizmanos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Agirre, X., Vizmanos, J., Calasanz, M. et al. Methylation of CpG dinucleotides and/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients. Oncogene 22, 1070–1072 (2003). https://doi.org/10.1038/sj.onc.1206236

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206236

Keywords

Search

Advanced search

Quick links